Skip to content

Drug interactions

Memantine-donepezil + Octreotide

Severity: Moderate

Memantine-donepezil and Octreotide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Donepezil can prolong the QT interval and cause bradycardia, and octreotide is associated with bradycardia and occasional QT prolongation. Together they may raise the risk of arrhythmia, especially with other risk factors.

What this interaction means in plain words

Memantine-donepezil and Octreotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Memantine-donepezil belongs to Central Nervous System; Octreotide belongs to Endocrine.

Evidence level: Low

Why it happens

Additive bradycardic and QT-prolonging effects.

What to do

Check baseline ECG and electrolytes in patients with cardiac risk factors. Monitor heart rate and rhythm during therapy.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Memantine-donepezil and Octreotide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Memantine-donepezil with Octreotide?

MediHelp rates the interaction as moderate. Memantine-donepezil and Octreotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Donepezil can prolong the QT interval and cause bradycardia, and octreotide is associated with bradycardia and occasional QT prolongation. Together they may raise the risk of arrhythmia, especially with other risk factors.

How serious is the interaction between Memantine-donepezil and Octreotide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Check baseline ECG and electrolytes in patients with cardiac risk factors. Monitor heart rate and rhythm during therapy.

What other medicines interact with Memantine-donepezil?

MediHelp also lists interactions of Memantine-donepezil with, for example, Dronedarone, Thioridazine, Amantadine. The full list is on the Memantine-donepezil page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in